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ABSTRACT 
It is a challenging time for the entire medical world to manage Coronavirus diseases 2019 
(COVID-19). The past few decades there is increase of epidemic diseases, with increase loss of 
lives due to rapidly spreading devastating epidemics; there is a need for protective 
immunization and prevention. The great hope in the control of infectious diseases is always 
vaccine. Vaccines have played an important part in the reduction of communicable diseases. 
However, Vaccines are continually monitored for safety, and like any medication, vaccine can 
cause side effects. Homoeopathy has been reportedly used with variable degree of success in 
influenza, cholera and other epidemics for 200 years. Homoeopathy has been used both 
therapeutically and /or prophylactic with success in past, using different approaches like Genus 
epidemicus, nosodes, and homoeopathic formulations.  
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INTRODUCTION 
 During December 2019, a novel 
Betacoronavirus provisionally named 2019 novel 
coronavirus (2019-nCoV), and subsequently officially 
renamed severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) by the International 
Committee on Taxonomy of Viruses (ICTV), causing 
coronavirus disease 2019 (or COVID-19), was 
associated with a cluster of respiratory tract 
infections in Wuhan, Hubei Province, China and has 
rapidly spread across continents.[1] On 30th January 
2020, the WHO declared the Chinese outbreak of 
COVID-19 to be a Public Health Emergency of 
International Concern posing a high risk to countries 
with vulnerable health systems.[2] In India, the first 
case was detected on 30th January 2020, thereafter 
day by day the number of cases of COVID-19 infection 
are increasing. With the spread over more than 28 
states isolation and social distancing is the general 
measures taken up by the public promoted by the 
government in the form of lock down since 24th 
March 2020.[3] The treatment of the patients with 
COVID‑19 is the major challenge as mortality ranges 
from 3% to 4% as compared to seasonal influenza 
(0.1%). Many potential drugs including ribavirin, 
interferon, lopinavir–ritonavir, corticosteroids, 
penciclovir, nitazoxanide, nafamostat, remdesivir, 
favipiravir, oseltamivir, azithromycin, baricitinib, and 
traditional Chinese medicine are being explored. 
However, as of now, there is no United States Food 
and Drug Administration approved drug or vaccine 
available for COVID‑19.[4] Development of any 
vaccine for immunization is the end result of years of 
discovery and development. Only a tiny percentage of 
candidate vaccines progress to licensing, making the 
costs of vaccine research and development extremely 
high. The vaccine development and testing follow a 
standard set of steps beginning with exploratory 
stage which includes the basic laboratory research 
and often lasts for 2–4 years.[5] Vaccination is one of 
the great public health achievements of human 
history. Vaccines used in national immunization 
programmes (NIPs) are considered safe and effective 
when used correctly. Vaccines are, however, not risk-
free and adverse events will occasionally occur 
following vaccination.[6] 
The preventive aspect of Homoeopathy is 
well known, and historically, Homoeopathy has 
reportedly been used for prevention during the 
epidemics of Cholera, Spanish Influenza, Yellow fever, 
Scarlet fever, Diphtheria, Typhoid etc. The approach 
to prevention in Homoeopathy is two-pronged. 
Homoeoprophylaxis or, prevention through 
Homoeopathy, can either be met through Genus 
Epidemicus (GE), which means a remedy which is 
found to be curative in the majority of cases of the 
same disease is also the most likely preventive for 
that disease; or through nosodes (medicine prepared 
from biological material of a disease). The former is 
identified through observation of several cases of an 
epidemic disease, and analysing the symptomatology 
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of those cases for the most indicated medicine. This 
medicine is considered to be the preventive medicine 
for the ongoing epidemic of that disease. The latter, 
on the other hand, once prepared through 
homoeopathic procedure, is considered a preventive 
for the disease it is prepared from, regardless of the 
overall presentation of that disease, which happens 
to change from time to time.[7] Also patients treated 
for influenza like illness with homeopathic 
medications are more satisfied with their treatment 
than other patients.[8] 
History of Homoeopathic prophylactic 
Preventive use of Homoeopathy was first 
applied in 1801 during an epidemic of scarlet fever in 
Konigslutter, Germany, when Hahnemann prescribed 
a single dose of Belladonna, as the GE to susceptible 
children in the town with 100% success.[9] Camphora, 
Cuprum metallicum and Veratrum album proved 
successful in different stages of the Cholera epidemic 
(1831–1832) and it was reported that mortality rate 
in European homoeopathic hospitals was 7%–10%, 
whereas with conventional treatment, it varied 
between 40 and 80%. Camphora saved another 
epidemic of Cholera (1846), where mortality rate 
amongst patients treated with Homoeopathy was 
5%–16% as compared to 54%–90% amongst 
patients treated conventionally.[10-14] 2806 patients 
were treated prophylactically with Variolinum 30 (a 
nosode) for prevention of smallpox in Iowa. Of the 
547 patients definitely exposed, only 14 developed 
the disease. Efficacy rate was 97.5%.[15]  
Genus Epidemicus  
In epidemics the medicine which covers most 
of the symptoms is declared as Genus Epidemicus 
and is recommended for use as prophylaxis, as well 
as treatment. There is anecdotal evidence that 
homeopathy was successful during the Spanish flu 
epidemic of 1918 to 1919, in which at least 20 million 
people died worldwide, more than 500,000 in the 
United States alone. According to the historian Julian 
Winston, the death rates for patients treated with 
Homeopathy were 1 to 2% compared with 30 to 60% 
mortality for those treated by conventional 
physicians. The genus epidemicus for the Spanish flu, 
according to Winston, was Gelsemium.[16] For a series 
of dengue fever outbreaks over the years in Brazil 
(2001–2012), identified GE Eupatorium perfoliatum 
or a combination of remedies based on the epidemic 
picture could significantly control the occurrence by 
80%–90%.[17] A study by Rejikumar et al. in 2006 on 
1061 people living in parts of Kerala badly affected 
by Chikungunya epidemic showed prevention in 
82.19% people after administration of homoeopathic 
medicine Eupatorium perfoliatum 200C (three doses 
daily for 5 consecutive days).[18] 
Nosodes  
Nosodes are used in different settings, 
practice as therapeutic remedy and public health as 
homoeoprophylaxis during epidemic outbreak of 
diseases. During an outbreak of meningococcal 
meningitis in 1974 at Guaratingueta, Sao Paulo, 
Brazil, homoeoprophylaxis with Meningococcinum 
nosode was administered to 18,640 people. This 
study showed 95% effectiveness over 6 months.[19] A 
similar study during an outbreak of this condition in 
the city of Blumenau, Brazil, in 1998, saw the nosode 
administered voluntarily to 65,826 people aged 
between 0 and 20 over 3 days at the public health 
clinics. The programme provided 95% protection 
from the severe bacterial infection after 6 months 
and 91% after 12 months, and the results were 
statistically significant.[20] In 1987, Fox concluded 
that Pertussin 30c as a prophylactic for whooping 
cough was 82% effective. However, the results 
reported by English though have tendency to prevent 
whooping cough were statistically insignificant. Both 
studies suggested for large sample trials.[21,22] During 
epidemic in France from 1984-1987, Oscillococcinum 
200C taken twice daily for 5 days significantly 
increased the rate of cure within two days (n=478, 
237 treated by medicine and 241 on placebo), 
absence of symptoms at 48 hours, relative risk 
estimate significantly favours homeopathy (p=0.048), 
no pain and no fever (p=0.048), recovery rate 
(headache, stiffness, articular pain, shivering 
reduction) at 48 hours better in homeopathy group 
(p=0.032).[23] A randomised double-blind prospective 
study of thirty participants compared standard 
vaccination to Influenzinum homoeopathic medicine 
for 13 weeks. This study found equal efficacy of the 
two methods in the prevention of influenza; however, 
the vaccination cohort experienced greater adverse 
reactions.[24] In another blinded randomised 
controlled trial in children in Brazil, wherein the 
homoeopathic medications used were either a 
homoeopathic nosode prepared from intact influenza 
A virus, or a homoeopathic complex frequently used 
in that region for influenza. This study showed a 
statistically significant reduction of influenza 
episodes in children receiving either of the two 
homoeopathic treatments versus placebo.[25]  
The study, conducted in 2007, used homoeo 
prophylactic interventions against the condition in 
three provinces of Cuba. They prepared a homoeo 
prophylactic formulation from dilutions of four 
circulating strains of leptospirosis and administered 
orally to 2.3 million persons at high risk in an 
epidemic in a region affected by natural disasters. 
After the homoeo prophylactic intervention, a 
significant decrease of the disease incidence was 
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observed in the intervention regions compared to the 
non‑intervention regions. The results were re-
evaluated, and the findings were consistent with 
those of the earlier results.[26] During a dengue 
outbreak in Delhi in 1996, the Central Council for 
Research in Homoeopathy distributed Dengueinum 
30 (prepared from the serum of person suffering 
from dengue fever) to 39,200 people who were not 
affected and residing in the adversely affected areas 
for preventing the dengue. Follow‑up after 10 days 
revealed appearance of fever, headache and body 
ache in five persons only.[27] A homoeopathic drug 
Malaria officinalis 200 was used for the mass 
prophylaxis for malaria in high malaria transmission 
season in selected 28 villages of district Shahdol of 
Madhya Pradesh state. Of the 28 villages, seven 
(25%) reported malaria case incidence ≤2 in 
6‑month period (July–December 2016). In the 
previous year, 23 (82%) villages reported the 
incidence of malaria as more than 2 in the same time 
period. Hence, the number of villages with ‘bi-annual 
malaria case incidence rate’ was reduced by 57%.[28]  
Homoeopathic Medicines and Immuno-
modulation 
There are several homoeopathy preclinical 
studies which shows the immunomodulatory action 
of homoeopathic medicines. In a study, for the acute 
and subacute toxicity of dengue nosodes, changes in 
behaviour or mortality were observed in Wistar rats, 
with increased serum levels of tumour necrosis 
factor‑α, interleukin (IL) IL‑1β, IL‑6, IL‑12 and IgM, 
although there were no signs of toxicity.[29] A study 
with Trypanosoma cruzi nosode on mice of different 
ages, infected with the concerned protozoa, 
modulated the inflammatory response with increased 
apoptosis and decreased serum levels of 
transforming growth factor‑beta (TGF‑β).[30] 
Psorinum, when tested in 6x potency on cancer cell 
lines, showed greater anticancer effects in A549 cells 
than in others. It triggered apoptosis in A549 cells via 
both up and down regulations of relevant signal 
proteins, including p53, caspase‑3, Bax and Bcl‑2.[31] 
A nosode prepared from the infectious influenza A 
virus (H3N2) on cell lines altered the cellular and 
biochemical features of MDCK and J774G8 cells.[32] 
Arsenic album has shown to affect HT29 cells and 
human macrophages. Also, it showed ↓NF-κB 
hyperactivity (reduced expression of reporter gene 
GFP in transfect HT29 cells), ↓TNF-α release in 
macrophages.[33] Preclinical studies conducted by 
CCRH in collaboration with School of Tropical 
Medicine, Kolkata, and in molecular studies 
conducted in collaboration with King’s George 
Medical University, Lucknow, observed protective 
effects through antiviral properties of Belladonna in 
Japanese encephalitis.[34-35] There are several other 
studies published which shows the 
immunomodulatory potential of homoeopathic 
medicines in preclinical studies.[36-41] 
Homoeopathic Formulations 
There are several reports, where 
combinations of homoeopathic remedies that are 
commonly prescribed for a specific disease were 
used to treat people during an epidemic. In Cuba, 
25,000 patients who tested positive for dengue were 
treated with homoeopathic complex containing 
medicines Bryonia Alba, Eupatorium p., Gelsemium s. 
and dengue nosode with significant improvement in 
clinical condition and reduction in days of stay at 
hospital.[42] In Pakistan, a homoeopathic complex of 
10 medicines including Bryonia alba, Rhus 
toxicodendron, Gelsemium sempervirens, Aconitum 
napellus, Eupatorium perfoliatum, China boliviana, 
Hamamelis, Citrullus colocynthis, Crotalus horridus 
and Phosphorus was given to 25 patients of dengue 
fever and the mean values of each of the criteria of 
both homoeopathic and standard treatment groups 
were compared. Better results were seen in the blood 
values within a week of prescription, as opposed to 
the standard maintenance therapy.[43] In early 2007, 
facing the challenge of controlling an outbreak of 
dengue, the Secretary of Health of the county of 
Macae, Rio de Janeiro, Brazil, carried out a 
“Homeopathy Campaign against Dengue.” 156,000 
doses of homoeopathic remedy were freely 
distributed in April and May 2007 to asymptomatic 
patients, according to the notion of “epidemic genus. 
The remedy used was a homoeopathic complex 
against dengue containing Phosphorus 30cH, Crotalus 
horridus 30cH and Eupatorium perfoliatum 30cH. The 
incidence of the disease in the first 3 months of 2008 
fell by 93% in comparison to the corresponding 
period in 2007, whereas in the rest of the state of Rio 
de Janeiro there was an increase of 128%.[44] In India, 
homoeoprophylaxis is also being used in the 
management of the Japanese Encephalitis epidemic in 
during the year 1999-2003, the government of 
Andhra Pradesh adopted Belladonna-Calcarea 
carbonica-Tuberculinum bovinum (BCT) regimen as 
preventive and the response was encouraging. The 
death rate was nil in the BCT distributed areas.[45]  
Homoeopathic research in epidemics 
In 2007, CCRH conducted preventive trial, 
where homoeopathic medicine Bryonia 30C was 
distributed as a preventive to 19, 750 people in 
Kerala and Bryonia alba 30C was found to be better 
than placebo in decreasing the incidence of 
Chikungunya in Kerala.[46] Multicenter, single blind, 
randomized, placebo controlled study was conducted 
by CCRH to evaluate the effect of homoeopathic 
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medicines in the treatment of Influenza like illness 
and to compare the efficacy of LM (50 millesimal) 
potency vis-à-vis centesimal (C) potency. In LM group 
(n=152), C group (n=147) or placebo (n=148) group. 
The study revealed the significant effect of 
individualized homoeopathic treatment in the 
patients suffering from ILI with no marked difference 
between LM and Centesimal groups. The medicines 
which were commonly prescribed were: Arsenic 
album, Bryonia alba, Rhustox., Belladonna, Nux 
vomica, Sepia, Phosphorus, Gelsemium, Sulphur, 
Natrum mur. and Aconitum napellus.[47] Central 
Council for Research in Homoeopathy carried out 
research studies for prevention and treatment of JE 
during its epidemics in eastern parts of U.P. in 1989, 
1991 and 1993. Belladonna 200, single dose was 
distributed as preventive to 3,22,812 persons in 96 
villages in three districts of U.P. In a follow up of 
39,250 persons, none of them reported any signs and 
symptoms of Japanese encephalitis.[48] Robert T 
Mathie, et al. observed that during, the 2009 A/H1N1 
influenza pandemic in India, several prominent 
symptoms and symptom/medicine associations, 
particularly temperature >38_C + cough + runny 
nose, were associated with Arsenicum album.[49] 
In the recent years, successes of adjunct 
homoeopathic treatment in epidemics of dengue and 
acute encephalitis syndrome have been reported in 
studies conducted by CCRH. Adjuvant homoeopathic 
treatment given to dengue haemorrhagic cases at a 
tertiary care hospital during the dengue outbreak in 
2015 in Delhi showed that patients who received 
Homoeopathy had rapid rise in platelet count and 
less number of days of hospital stay compared to 
those who received standard care alone. Similarly, in 
acute encephalitis syndrome/Japanese encephalitis, 
Homoeopathy as an adjuvant to the Institutional 
Management protocol (IMP) could decrease death 
rate by 15% in comparison to those who received 
only IMP.[50-51] Another prospective observational 
study was conducted on 126 patients of Chikungunya 
in Chikungunya Fever (CF) and in Post-Chikungunya 
Chronic Arthritis (PCCA) in a Delhi Government 
Homeopathic Dispensary for a period of 6 months. A 
single homeopathic medicine was prescribed for each 
patient after case taking with the help of Materia 
Medica and/or Repertory. The study resulted in 
complete recovery was seen in 84.5% CF cases in a 
mean time of 6.8 days. 90% cases of PCCA recovered 
completely in a mean time of 32.5 days.[52]  
Veterinary Homoeopathy 
Few animal studies were conducted to assess 
the prophylactic effect of Homoeopathic medicines in 
diseases like Anthrax, Colibacillosis, Bovine mastitis 
etc. A study by Dabbir BR. found during an Anthrax 
outbreak in an endemic place of India, all the sheep 
and goats were protected from Anthrax with a single 
dose of Anthracinum CH 200 both in non\endemic 
villages.[53] In a review article published by Zeise and 
Fritz, observed that the selected studies showed a 
positive treatment outcome of homeopathy and 
possibility to reduce antibiotic use by 75% in bovine 
mastitis[54] In another study conducted by Coelho C. 
et al to assess homoeopathic treatment as preventive 
against colibacillosis in newborn piglets concluded 
that homeopathic and biotherapic treatment were 
more effective than antibiotics in the control of 
diarrhoea in newborn piglets.[55] 
Agro-Homoeopathy 
There are studies to support the premise that 
homeopathic and high dilution preparations have the 
potential to be effective on replacing pesticides that 
are used on crops and that “Similia Principle” is very 
useful to overcome abiotic stresses of plants.[56-57] 
Another randomised study conducted on Mangifera 
indica (Mango), by using selected homeopathic 
medicines of different potencies and concentrations, 
inferred that all of the selected homeopathic 
medicines exhibited significant (p<0.0001) antifungal 
effect against C. gloeosporioides at 3000 ppm on OMA 
contained Petri-plates. Among the tested medicines 
Arsenicum album showed significant (p<0.0001) 
inhibition against C. gloeosporioides in controlling the 
disease [58].  
CONCLUSION 
One of the most important challenges of the 
public health is to control these epidemic outbreaks, 
which are diseases that spread rapidly and widely, 
affecting many individuals in the population at the 
same time. The recent COVID-19 outbreak has been 
deemed a global health emergency. The 
homoeopathic intervention has played a significant 
role in epidemics, not only by treating, but also by 
reducing the mortality. Administration of the specific 
Genus Epidemicus, derived after careful assessment 
of the characteristic picture of the disease across 
regions, and treatment of symptomatic cases with 
adjuvant individualised Homoeopathy, can be the 
most viable, safe, inexpensive and effective approach 
to manage COVID‑19 disease outbreak globally. In 
India, after the Ministry of AYUSH issued an advisory 
early in January 2020, for prophylactic application of 
Arsenicum album 30, many institutions started 
distributing it to the masses. Cuba has also issued 
directions for distribution of a combination 
homoeopathic remedy to the unaffected population, 
while physicians in Hong Kong and Italy have been 
treating a few patients of COVID‑19 with 
Homoeopathy.59 Homoeopathy could play important 
role both therapeutically and /or prophylactic with 
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success in management of COVID-19. However, 
establishing the preventive use of Homeopathy in 
public health setting is a challenge. High quality 
safety and pre-clinical studies, as well as robust 
clinical research is required to be undertaken for 
establishing role of Homoeopathy in epidemics. 
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